Dr. Muthu completed his Ph.D. research work under the supervision of Prof. Sanjay Singh from the Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi, India. He has done his post-doctoral research in cancernanotechnology under the supervision of Prof. Feng Si-Shen from the National University of Singapore in 2010 & 2014 (2yrs). Dr. Muthu is a Professor of Pharmaceutics in the Department of Pharmaceutical Engineering & Technology, IIT(BHU).[1]
Muthu received various scientific awards from government and non-government organization including the BOYSCAST Fellowship, Academic Excellence Award, CREST Award, IMS-Research Publication Award, BHU Vice-Chancellor's Medical Research Award, International Faculty Award, and Best Young Scientist Award.[8] He is the recipient of the BIRAC-DBT-Gandhian Young Technological Innovation (GYTI) Award in 2017, from the President of India for advancing nanomedicine research.[9][10] His research work has secured Rs. 2.19 crores funds from various government funding agencies, which includes SERB, DST, DBT, ICMR, and BIRAC. He has been elected as a Member of the National Academy of Sciences (NASI), India in 2019. Additionally, he is a fellow of the Royal Society of Chemistry (FRSC). Recently, he has developed targeted nanomedicine for breast cancer therapy with reduced systemic toxicity, which has successfully demonstrated its efficacy in preclinical studies.[11]
This article needs additional or more specific categories. Please help out by adding categories to it so that it can be listed with similar articles.(February 2021)